Post-partum haemorrhage and the WOMAN trial

International Journal of Epidemiology

Volumn 39, Issue 4, 2010, Pages 949-950

  Cook, Lisa ^a   Roberts, Ian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANEXAMIC ACID;

CLINICAL TRIAL; EDITORIAL; FEMALE; HUMAN; HYSTERECTOMY; LOADING DRUG DOSE; MATERNAL MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; TRAUMATIC HEMATOMA;

ANTIFIBRINOLYTIC AGENTS; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; TRANEXAMIC ACID;

EID: 77956282457     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq138     Document Type: Editorial

References (8)

1. Hogan MC, Foreman KJ, Naghavi M et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010;375:1609-23.
2. Ronsmans C, Graham WJ. Maternal mortality: who, when, where, and why. Lancet 2006;368:1189-200.
3. World Health Organisation. WHO Recommendations for the Prevention of Postpartum Haemorrhage. Geneva: World Health Organisation, 2007.
4. Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U. Enzyme controlling medicines: introduction. Semin Thromb Hemost 1997;23:493-501.
5. Henry DA, Carless PA, Moxey AJ et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007;4:CD001886.
6. CRASH-2 Trial Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23-32.
7. Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti-fibrinolytic agents in postpartum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009;9:29.
8. Shakur H, Elbourne D, Gulmezoglu M et al. The WOMAN Trial (World Maternal Antifi brinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010;11:40.